Global SARS-CoV-2 surveillance through mid-2026 shows persistently low activity, with WHO data indicating just 3.8% test positivity, roughly 22,000 cases, and 1,233 hospitalizations across reporting countries in recent 28-day periods. Ongoing Omicron subvariants such as BA.3.2 exhibit immune escape and regional increases but lack the virulence or explosive growth needed for a new pandemic declaration, consistent with endemic circulation patterns. Trader consensus at 95% "No" reflects this stable, monitored trajectory backed by CDC and ECDC tracking. A realistic shift could occur if a novel, highly transmissible strain emerges with enhanced severity or if zoonotic spillover from related coronaviruses like MERS-CoV accelerates undetected.